Inviting an author to review:
Find an author and click ‘Invite to review selected article’ near their name.
Search for authorsSearch for similar articles
4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      ‘We don’t live in a harm reduction world, we live in a prohibition world’: tensions arising in the design of drug alerts

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Drug alerts designed for health and community workforces have potential to avert acute harms associated with unpredictable illicit drug markets, by preparing workers to respond to unusual drug-related events, and distribute information to service users. However, the design of such alerts is complicated by diverse needs of individuals, and broader socio-political contexts. Here, we discuss the tensions that arose in the process of co-designing drug alert templates with health and community workers.

          Methods

          We conducted five in-depth digital co-design workshops with 31 workers employed in alcohol and other drug and urgent care settings. Our approach to analysis was informed by Iterative Categorisation and reflexive thematic analysis methods.

          Results

          We identified five key tensions. First, there is a need to provide comprehensive information to meet the information needs of a diverse group of workers with varying knowledge levels, while also designing alerts to be clear, concise, and relevant to the work of individuals. Second, it is important that alerts do not create ‘information overload’; however, it is also important that information should be available to those who want it. Third, alert design and dissemination must be perceived to be credible, to avoid ‘alert scepticism’; however, credibility is challenging to develop in a broader context of criminalisation, stigmatisation, and sensationalism. Fourth, alerts must be carefully designed to achieve ‘intended effects’ and avoid unintended effects, while acknowledging that it is impossible to control all potential effects. Finally, while alerts may be intended for an audience of health and community workers, people who use drugs are the end-users and must be kept front of mind in the design process.

          Conclusions

          The co-design process revealed complexities in designing drug alerts, particularly in the context of stigmatised illicit drug use, workforce diversity, and dissemination strategies. This study has highlighted the value of developing these important risk communication tools with their target audiences to ensure that they are relevant, useful, and impactful. The findings have informed the development of our drug alert prototypes and provide local context to complement existing best-practice risk-communications literature.

          Supplementary Information

          The online version contains supplementary material available at 10.1186/s12954-022-00716-3.

          Related collections

          Most cited references62

          • Record: found
          • Abstract: not found
          • Article: not found

          Using thematic analysis in psychology

            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Reflecting on reflexive thematic analysis

              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              An overview of clinical decision support systems: benefits, risks, and strategies for success

              Computerized clinical decision support systems, or CDSS, represent a paradigm shift in healthcare today. CDSS are used to augment clinicians in their complex decision-making processes. Since their first use in the 1980s, CDSS have seen a rapid evolution. They are now commonly administered through electronic medical records and other computerized clinical workflows, which has been facilitated by increasing global adoption of electronic medical records with advanced capabilities. Despite these advances, there remain unknowns regarding the effect CDSS have on the providers who use them, patient outcomes, and costs. There have been numerous published examples in the past decade(s) of CDSS success stories, but notable setbacks have also shown us that CDSS are not without risks. In this paper, we provide a state-of-the-art overview on the use of clinical decision support systems in medicine, including the different types, current use cases with proven efficacy, common pitfalls, and potential harms. We conclude with evidence-based recommendations for minimizing risk in CDSS design, implementation, evaluation, and maintenance.
                Bookmark

                Author and article information

                Contributors
                monica.barratt@rmit.edu.au
                Journal
                Harm Reduct J
                Harm Reduct J
                Harm Reduction Journal
                BioMed Central (London )
                1477-7517
                9 January 2023
                9 January 2023
                2023
                : 20
                : 3
                Affiliations
                [1 ]GRID grid.1017.7, ISNI 0000 0001 2163 3550, Social and Global Studies Centre, , RMIT University, ; Melbourne, Australia
                [2 ]GRID grid.1005.4, ISNI 0000 0004 4902 0432, Drug Policy Modelling Program, Social Policy Research Centre, , UNSW Sydney, ; Sydney, Australia
                [3 ]GRID grid.414366.2, ISNI 0000 0004 0379 3501, Turning Point, , Eastern Health Statewide Services, ; Richmond, Australia
                [4 ]GRID grid.1002.3, ISNI 0000 0004 1936 7857, Monash Addiction Research Centre, Eastern Health Clinical School, , Monash University, ; Melbourne, Australia
                [5 ]Harm Reduction Victoria (DanceWize), North Melbourne, Australia
                [6 ]Department of Health, Victoria State Government, Melbourne, Australia
                [7 ]360Edge, Melbourne, Australia
                [8 ]GRID grid.1032.0, ISNI 0000 0004 0375 4078, National Drug Research Institute, , Curtin University, ; Perth, Australia
                [9 ]GRID grid.1014.4, ISNI 0000 0004 0367 2697, Law and Commerce, , Flinders University, ; Adelaide, Australia
                [10 ]GRID grid.1005.4, ISNI 0000 0004 4902 0432, National Drug and Alcohol Research Centre, , UNSW, ; Sydney, Australia
                [11 ]Safer Care Victoria, Melbourne, Australia
                [12 ]GRID grid.1002.3, ISNI 0000 0004 1936 7857, Department of Paramedicine, , Monash University, ; Melbourne, Australia
                [13 ]GRID grid.1017.7, ISNI 0000 0001 2163 3550, Digital Ethnography Research Centre, , RMIT University, ; Melbourne, Australia
                Article
                716
                10.1186/s12954-022-00716-3
                9829230
                36624508
                3780e5e2-c71e-4753-ad9d-10d6bc157211
                © The Author(s) 2023

                Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

                History
                : 23 March 2022
                : 22 October 2022
                Funding
                Funded by: National Centre for Clinical Research on Emerging Drugs
                Award ID: NCR3SF03
                Award ID: NCR3SF03
                Award ID: NCR3SF03
                Award ID: NCR3SF03
                Award ID: NCR3SF03
                Award ID: NCR3SF03
                Award ID: NCR3SF03
                Award ID: NCR3SF03
                Award ID: NCR3SF03
                Award ID: NCR3SF03
                Award ID: NCR3SF03
                Award Recipient :
                Categories
                Research
                Custom metadata
                © The Author(s) 2023

                Health & Social care
                drug alerts,early warning system,workforce,drug risk communication,co-design,drug checking,credibility,stigma,harm reduction,tensions

                Comments

                Comment on this article